EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Loss of cancer cell‐derived ADAM15 alters the tumor microenvironment in colorectal tumors

Laia Puig-Blasco, Krzysztof B Piotrowski, Signe R Michaelsen, Nicolai S Bager, Aušrinė Areškevičiūtiė, Marie-Louise Thorseth, Xiao-Feng Sun, Ulrich Auf dem Keller, Bjarne W Kristensen, Daniel H Madsen, Sebastian P Gnosa, Marie Kveiborg iD

International Journal of Cancer · 2023

DOI: 10.1002/ijc.34695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2023. Verfasst von Laia Puig-Blasco und 11 weiteren Autor:innen. Beteiligte Einrichtung: Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Tumor Microenvironment, Colorectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Danmarks Frie Forskningsfond, Kræftens Bekæmpelse, Lundbeck Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor progression and response to treatment are highly affected by interactions between cancer cells and the tumor microenvironment (TME). Many of the soluble factors and signaling receptors involved in this crosstalk are shed by a disintegrin and metalloproteinases (ADAMs). Upregulation of ADAM15 has been linked to worse survival in cancer patients and a tumor‐promoting function both in vitro and in murine cancer models. Although ADAM15 has been involved in cell‐cell and cell‐extracellular matrix interactions, its role in the crosstalk between cancer cells and the TME in vivo remains unexplored. Therefore, we aimed to understand how ADAM15 regulates the cell composition of the TME and how it affects tumor progression. Here, we showed an upregulation of ADAM15 in tumor tissues from rectal cancer patients. Subcutaneous injection of wildtype and ADAM15‐knockout CT26 colon cancer cells in syngeneic mice confirmed the protumorigenic role of ADAM15. Profiling of tumors revealed higher immune cell infiltration and cancer cell apoptosis in the ADAM15‐deficient tumors. Specifically, loss of ADAM15 led to a reduced number of granulocytes and higher infiltration of antigen‐presenting cells, including dendritic cells and macrophages, as well as more T cells. Using in vitro assays, we confirmed the regulatory effect of ADAM15 on macrophage migration and identified ADAM15‐derived CYR61 as a potential molecular mediator of this effect. Based on these findings, we speculate that targeting ADAM15 could increase the infiltration of immune cells in colorectal tumors, which is a prerequisite for effective immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentColorectal NeoplasmsHumansMiceAnimalsSignal TransductionCell MovementMembrane ProteinsADAM Proteins

Stichwörter der Autor:innen

CCN1cancerimmunotherapymacrophagesmetargidin

Substanzen

ADAM15 protein, humanMembrane ProteinsADAM Proteins

Autor:innen und Institutionen

  • Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Danish Reference Center for Prion Diseases, Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark.
  • National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark.
  • Department of Oncology and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.

ORCID-Profile: Marie Kveiborg

Förderung

  • Danmarks Frie Forskningsfond
  • Kræftens Bekæmpelse
  • Lundbeck Foundation
  • Novo Nordisk Fonden

Zitieren

APA

Puig-Blasco, L., Piotrowski, K. B., Michaelsen, S. R., Bager, N. S., Areškevičiūtiė, A., Thorseth, M. L., Sun, X. F., Keller, U. A. D., Kristensen, B. W., Madsen, D. H., Gnosa, S. P., & Kveiborg, M. (2023). Loss of cancer cell‐derived ADAM15 alters the tumor microenvironment in colorectal tumors. International Journal of Cancer. https://doi.org/10.1002/ijc.34695

Vancouver

Puig-Blasco L, Piotrowski KB, Michaelsen SR, Bager NS, Areškevičiūtiė A, Thorseth ML, et al. Loss of cancer cell‐derived ADAM15 alters the tumor microenvironment in colorectal tumors. International Journal of Cancer. 2023. doi:10.1002/ijc.34695

BibTeX
@article{PuigBlasco2023,
  author = {Puig-Blasco, Laia and Piotrowski, Krzysztof B and Michaelsen, Signe R and Bager, Nicolai S and Areškevičiūtiė, Aušrinė and Thorseth, Marie-Louise and Sun, Xiao-Feng and Keller, Ulrich Auf dem and Kristensen, Bjarne W and Madsen, Daniel H and Gnosa, Sebastian P and Kveiborg, Marie},
  title = {Loss of cancer cell‐derived ADAM15 alters the tumor microenvironment in colorectal tumors},
  journal = {International Journal of Cancer},
  year = {2023},
  doi = {10.1002/ijc.34695}
}
Kostenlos starten →